Literature DB >> 32981131

Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet.

Jocelyn A Silvester1,2,3,4, Isabel Comino5, Lisa N Rigaux6, Veronica Segura5, Kathy H Green6, Angel Cebolla7, Dayna Weiten8, Remedios Dominguez7, Daniel A Leffler1,3, Francisco Leon9, Charles N Bernstein4, Lesley A Graff4, Ciaran P Kelly1,3, Carolina Sousa5, Donald R Duerksen4,6.   

Abstract

BACKGROUND: A major deficit in understanding and improving treatment in coeliac disease (CD) is the lack of empiric data on real world gluten exposure. AIMS: To estimate gluten exposure on a gluten-free diet (GFD) using immunoassays for gluten immunogenic peptides (GIP) and to examine relationships among GIP detection, symptoms and suspected gluten exposures
METHODS: Adults with biopsy-confirmed CD on a GFD for 24 months were recruited from a population-based inception cohort. Participants kept a diary and collected urine samples for 10 days and stools on days 4-10. 'Doggie bags' containing ¼ portions of foods consumed were saved during the first 7 days. Gluten in food, stool and urine was quantified using A1/G12 ELISA.
RESULTS: Eighteen participants with CD (12 female; age 21-70 years) and three participants on a gluten-containing diet enrolled and completed the study. Twelve out of 18 CD participants had a median 2.1 mg gluten per exposure (range 0.2 to >80 mg). Most exposures were asymptomatic and unsuspected. There was high intra-individual variability in the interval between gluten ingestion and excretion. Participants were generally unable to identify the food.
CONCLUSIONS: Gluten exposure on a GFD is common, intermittent, and usually silent. Excretion kinetics are highly variable among individuals. The amount of gluten varied widely, but was typically in the milligram range, which was 10-100 times less than consumed by those on an unrestricted diet. These findings suggest that a strict GFD is difficult to attain, and specific exposures are difficult to detect due to variable time course of excretion.
© 2020 John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32981131      PMCID: PMC7780203          DOI: 10.1111/apt.16075

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  42 in total

1.  Gluten contamination in food services and industry: A systematic review.

Authors:  Ana Luísa Falcomer; Letícia Santos Araújo; Priscila Farage; Jordanna Santos Monteiro; Eduardo Yoshio Nakano; Renata Puppin Zandonadi
Journal:  Crit Rev Food Sci Nutr       Date:  2018-12-22       Impact factor: 11.176

2.  Selective capture of most celiac immunogenic peptides from hydrolyzed gluten proteins.

Authors:  María de Lourdes Moreno; Alba Muñoz-Suano; Miguel Ángel López-Casado; María Isabel Torres; Carolina Sousa; Ángel Cebolla
Journal:  Food Chem       Date:  2016-02-10       Impact factor: 7.514

Review 3.  Practical insights into gluten-free diets.

Authors:  Jacalyn A See; Katri Kaukinen; Govind K Makharia; Peter R Gibson; Joseph A Murray
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

4.  Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis.

Authors:  H Matsuo; K Morimoto; T Akaki; S Kaneko; K Kusatake; T Kuroda; H Niihara; M Hide; E Morita
Journal:  Clin Exp Allergy       Date:  2005-04       Impact factor: 5.018

5.  Peptide excretion in celiac disease.

Authors:  W H Reichelt; J Ek; M Stensrud; K L Reichelt
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-03       Impact factor: 2.839

6.  A simple validated gluten-free diet adherence survey for adults with celiac disease.

Authors:  Daniel A Leffler; Melinda Dennis; Jessica B Edwards George; Shailaja Jamma; Suma Magge; Earl F Cook; Detlef Schuppan; Ciaran P Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-11       Impact factor: 11.382

7.  Development of the Dietitian Integrated Evaluation Tool for Gluten-free Diets (DIET-GFD).

Authors:  Amporn Atsawarungruangkit; Jocelyn A Silvester; Dayna Weiten; Kathy L Green; Kaitlyn E Wilkey; Lisa N Rigaux; Charles N Bernstein; Lesley A Graff; John R Walker; Donald R Duerksen
Journal:  Nutrition       Date:  2020-03-20       Impact factor: 4.008

Review 8.  Gluten Immunogenic Peptides as Standard for the Evaluation of Potential Harmful Prolamin Content in Food and Human Specimen.

Authors:  Ángel Cebolla; María de Lourdes Moreno; Laura Coto; Carolina Sousa
Journal:  Nutrients       Date:  2018-12-05       Impact factor: 5.717

9.  Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet.

Authors:  Isabel Comino; Verónica Segura; Luis Ortigosa; Beatríz Espín; Gemma Castillejo; José Antonio Garrote; Carlos Sierra; Antonio Millán; Carmen Ribes-Koninckx; Enriqueta Román; Alfonso Rodríguez-Herrera; Jacobo Díaz; Jocelyn Anne Silvester; Ángel Cebolla; Carolina Sousa
Journal:  Aliment Pharmacol Ther       Date:  2019-05-10       Impact factor: 8.171

10.  Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide.

Authors:  Belén Morón; Michael T Bethune; Isabel Comino; Hamid Manyani; Marina Ferragud; Manuel Carlos López; Angel Cebolla; Chaitan Khosla; Carolina Sousa
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more
  11 in total

1.  Non-Responsive and Refractory Coeliac Disease: Experience from the NHS England National Centre.

Authors:  Hugo A Penny; Anupam Rej; Elisabeth M R Baggus; Sarah H Coleman; Rosalie Ward; Graeme Wild; Gerd Bouma; Nick Trott; John A Snowden; Josh Wright; Simon S Cross; Marios Hadjivassiliou; David S Sanders
Journal:  Nutrients       Date:  2022-07-05       Impact factor: 6.706

2.  Oral Consumption of Bread from an RNAi Wheat Line with Strongly Silenced Gliadins Elicits No Immunogenic Response in a Pilot Study with Celiac Disease Patients.

Authors:  María H Guzmán-López; Susana Sánchez-León; Miriam Marín-Sanz; Isabel Comino; Verónica Segura; Luis Vaquero; Octavio M Rivero-Lezcano; Jorge Pastor; Carolina Sousa; Santiago Vivas; Francisco Barro
Journal:  Nutrients       Date:  2021-12-18       Impact factor: 5.717

3.  Individual variability in patterns and dynamics of fecal gluten immunogenic peptides excretion after low gluten intake.

Authors:  Laura Coto; Carolina Sousa; Angel Cebolla
Journal:  Eur J Nutr       Date:  2022-01-07       Impact factor: 4.865

4.  Determination of Urinary Gluten Immunogenic Peptides to Assess Adherence to the Gluten-Free Diet: A Randomized, Double-Blind, Controlled Study.

Authors:  Chiara Monachesi; Anil K Verma; Giulia N Catassi; Elisa Franceschini; Simona Gatti; Rosaria Gesuita; Elena Lionetti; Carlo Catassi
Journal:  Clin Transl Gastroenterol       Date:  2021-10-06       Impact factor: 4.488

5.  Application of a Platform for Gluten-Free Diet Evaluation and Dietary Advice: From Theory to Practice.

Authors:  Gesala Perez-Junkera; Maialen Vázquez-Polo; Francisco Javier Eizagirre; Laura Benjumea; Carlos Tutau; Blanca Esteban; Jonatan Miranda; Idoia Larretxi; Virginia Navarro; Itziar Churruca; Arrate Lasa
Journal:  Sensors (Basel)       Date:  2022-01-19       Impact factor: 3.576

6.  Urinary Gluten Peptide Determination: Results Are Results, Even When They Contradict Aprioristic Expectations.

Authors:  Chiara Monachesi; Anil K Verma; Giulia N Catassi; Elisa Franceschini; Simona Gatti; Rosaria Gesuita; Elena Lionetti; Carlo Catassi
Journal:  Clin Transl Gastroenterol       Date:  2022-04-01       Impact factor: 4.396

7.  E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in in vitro gastrointestinal digesta of food matrices made of soft and durum wheat.

Authors:  Gianfranco Mamone; Maria Cristina Comelli; Serena Vitale; Luigia Di Stasio; Katharina Kessler; Ilaria Mottola; Francesco Siano; Linda Cavaletti; Carmen Gianfrani
Journal:  Front Nutr       Date:  2022-09-08

Review 8.  Challenges of Monitoring the Gluten-Free Diet Adherence in the Management and Follow-Up of Patients with Celiac Disease.

Authors:  Herbert Wieser; Ángela Ruiz-Carnicer; Verónica Segura; Isabel Comino; Carolina Sousa
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

Review 9.  New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.

Authors:  Verónica Segura; Ángela Ruiz-Carnicer; Carolina Sousa; María de Lourdes Moreno
Journal:  Nutrients       Date:  2021-06-23       Impact factor: 5.717

10.  Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease.

Authors:  M Ines Pinto-Sanchez; Jocelyn A Silvester; Benjamin Lebwohl; Daniel A Leffler; Robert P Anderson; Amelie Therrien; Ciaran P Kelly; Elena F Verdu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-15       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.